THERESON is an Italian biomedical company. Years of clinical and scientific researches have led to the development of TMR®, Therapeutic Magnetic Resonance, a patented innovative technology for the clinical and home treatment of: vascular pathologies and in particular microcirculation, wounds and chronic ulcers of different aetiology; of orthopedic diseases, surgical or traumatic wounds, chronic osteoarticular pathologies and pain management. TMR® is a form of stimulation with PEMF pulsed magnetic fields, at low intensity and low frequencies. Several studies, conducted in co-operation with important clinical institutions and university centers, have measured and demonstrated the effectiveness of TMR®. Therefore, it can be stated that at the moment it is the only method able to favor the healing processes of deep lesions, from skin to bone, both acute and chronic. In fact, TMR® promotes the proliferation of the cells most involved in the healing processes by reducing free radicals, oxidative stress and inflammation.